Talking Rheumatology Research
Talking Rheumatology Research
✓

Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis

00:10:32
Podcasts
RSS
Link

ABOUT THIS EPISODE

Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. 

Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better access to diagnostic tools, and a multidisciplinary approach to managing this condition.

You can read this article [https://doi.org/10.1093/rheumatology/kead604] in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.

Medicine
Health & Fitness
Medicine
English
United Kingdom
Use API to fetch this episode in JSON

IN THIS EPISODE

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Talking Rheumatology Research.
Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Ep 39. UK JIA Biologics Register: stopping biologics for remission

Ep 39. UK JIA Biologics Register: stopping biologics for remission

What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, b…
00:10:06
SHARE
SAVE
Ep 41. Addressing the leaky pipeline

Ep 41. Addressing the leaky pipeline

What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatolog…
00:17:56
SHARE
SAVE
Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy

Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy

We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see. Ernest will take the reins from Dr Marwan Bu…
00:04:41
SHARE
SAVE
Ep 43. The metaverse: a new frontier for rheumatology

Ep 43. The metaverse: a new frontier for rheumatology

Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients. Listen now to hear about the current technological developments and what this means for future clinical practice!  You …
00:11:16
SHARE
SAVE
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab. Listen now to hear…
00:17:53
SHARE
SAVE
Disclaimer: The podcast and artwork embedded on this page are from British Society for Rheumatology, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

RECOMMENDATIONS
Use API to fetch this episode